TW370460B - Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative... - Google Patents

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative...

Info

Publication number
TW370460B
TW370460B TW085100961A TW85100961A TW370460B TW 370460 B TW370460 B TW 370460B TW 085100961 A TW085100961 A TW 085100961A TW 85100961 A TW85100961 A TW 85100961A TW 370460 B TW370460 B TW 370460B
Authority
TW
Taiwan
Prior art keywords
treatment
hyperlipoproteinaemia
hypertriglyceridaemia
hypercholesterolaemia
hyperlipidaemia
Prior art date
Application number
TW085100961A
Other languages
Chinese (zh)
Inventor
Michael Shalmi
Niels Korsgaard
Steven Bain
Birgitte Hjort Guldhammer
Jan Ulrik Weis
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of TW370460B publication Critical patent/TW370460B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides novel uses of compounds of general formula I wherein R1, R4 and R5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R2 and R3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment.
TW085100961A 1995-01-13 1996-01-26 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative... TW370460B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK4195 1995-01-13

Publications (1)

Publication Number Publication Date
TW370460B true TW370460B (en) 1999-09-21

Family

ID=27675488

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085100961A TW370460B (en) 1995-01-13 1996-01-26 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative...

Country Status (2)

Country Link
TW (1) TW370460B (en)
ZA (1) ZA96251B (en)

Also Published As

Publication number Publication date
ZA96251B (en) 1997-02-20

Similar Documents

Publication Publication Date Title
MX9700886A (en) New substituted oxazolidinones.
HK1063788A1 (en) Biologically active methylene blue derivatives
MX9604020A (en) Arylalkyldiazinones.
TR200000129T2 (en) Brand new spiroazabicyclic heterocyclic compounds.
AP9701041A0 (en) Pyridylpyrrole compounds.
AU1367497A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
NO983178L (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
BG104447A (en) Biphenylamidine derivatives
HU9601587D0 (en) Antracycline derivatives
TW370460B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative...
NO973340L (en) Use of 3,4-diphenylchromanes in the preparation of a pharmaceutical composition for the treatment or prophylaxis of obesity
MX9705214A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative tre
SE9603285D0 (en) New compounds
NO973242L (en) Use of 3,4-diphenylchromanes for the preparation of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiological gynecomastia
CA2283083A1 (en) Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
MX9705379A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis.
MX9705390A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders.
IL114646A0 (en) Method of inhibiting leukotriene biosynthesis
HU9500710D0 (en) Ureido-acetamide derivatives, preparation thereof and drugs containing same
MX9705136A (en) Antifungal fusacandins.
MX9605415A (en) Propiophenone derivative and processes for preparing the same.